BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7184374)

  • 1. [Effect of NK-421 (Bestatin) and Ge-132 on the cytotoxicity of spleen cells obtained from the tumor-bearing mice].
    Ono M; Oka T; Yoshihara H; Tanaka N; Miwa H; Mannami T; Konaga E; Orita K
    Gan To Kagaku Ryoho; 1982 Oct; 9(10):1771-7. PubMed ID: 7184374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissociation of natural killer activity and antibody-dependent cellular cytotoxicity in spleen cells of tumor bearing mice.
    Ono M; Tanaka N; Orita K
    Acta Med Okayama; 1983 Aug; 37(4):367-76. PubMed ID: 6605026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Suppression of tumor growth by peritoneal macrophages isolated from mice treated with carboxyethylgermanium sesquioxide (Ge-132)].
    Suzuki F
    Gan To Kagaku Ryoho; 1985 Nov; 12(11):2122-8. PubMed ID: 4062310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of interferon and activation of NK cells and macrophages in mice by oral administration of Ge-132, an organic germanium compound.
    Aso H; Suzuki F; Yamaguchi T; Hayashi Y; Ebina T; Ishida N
    Microbiol Immunol; 1985; 29(1):65-74. PubMed ID: 2581116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of bestatin on syngeneic tumors in mice.
    Abe F; Shibuya K; Uchida M; Takahashi K; Horinishi H; Matsuda A; Ishizuka M; Takeuchi T; Umezawa H
    Gan; 1984 Jan; 75(1):89-94. PubMed ID: 6586596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Induction of interferon and activation of NK cells and macrophages in mice by oral administration of Ge-132, an organic germanium compound].
    Aso H; Suzuki F; Yamaguchi T; Hayashi Y; Ebina T; Ishida N
    Gan To Kagaku Ryoho; 1982 Nov; 9(11):1976-80. PubMed ID: 6191691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Augmentation of NK activity in peripheral blood lymphocytes of cancer patients by intermittent GE-132 administration].
    Tanaka N; Ohida J; Ono M; Yoshiwara H; Beika T; Terasawa A; Yamada J; Morioka S; Mannami T; Orita K
    Gan To Kagaku Ryoho; 1984 Jun; 11(6):1303-6. PubMed ID: 6732257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the mechanisms of action of the immunomodulator Bestatin in various screening test systems.
    Schorlemmer HU; Bosslet K; Dickneite G; Lüben G; Sedlacek HH
    Behring Inst Mitt; 1984 May; (74):157-73. PubMed ID: 6383322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo and in vitro modulation of NK and ADCC activities of mouse spleen cells by peptidoglycan monomer (PGM).
    Gabrilovac J; Tomasić J; Boranić M; Martin-Kleiner I; Osmak M
    Res Exp Med (Berl); 1989; 189(4):265-73. PubMed ID: 2813963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do tuftsin and bestatin constitute a biopharmacological immunoregulatory system?
    Mathé G
    Cancer Detect Prev Suppl; 1987; 1():445-55. PubMed ID: 3319151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antitumor effect in mice of an organic germanium compound (Ge-132) when different administration methods are used].
    Aso H; Shibuya E; Suzuki F; Nakamura T; Inoue H; Ebina T; Ishida N
    Gan To Kagaku Ryoho; 1985 Dec; 12(12):2345-51. PubMed ID: 4073929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiviral activity of carboxyethylgermanium sesquioxide (Ge-132) in mice infected with influenza virus.
    Aso H; Suzuki F; Ebina T; Ishida N
    J Biol Response Mod; 1989 Apr; 8(2):180-9. PubMed ID: 2471817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Augmentation of murine natural killer cell and antibody dependent cellular cytotoxicity activities by Phyllanthus emblica, a new immunomodulator.
    Suresh K; Vasudevan DM
    J Ethnopharmacol; 1994 Aug; 44(1):55-60. PubMed ID: 7990505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correction of immunodeficiency in aged mice by levamisole and bestatin administration.
    Bruley-Rosset M; Florentin I; Kiger N; Schulz JI; Mathé G
    Recent Results Cancer Res; 1980; 75():139-46. PubMed ID: 7232825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological activities and antitumor mechanism of an immunopotentiating organogermanium compound, Ge-132 (review).
    Brutkiewicz RR; Suzuki F
    In Vivo; 1987; 1(4):189-203. PubMed ID: 2979786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cooperation of lymphokine(s) and macrophages in expression of antitumor activity of carboxyethylgermanium sesquioxide (Ge-132).
    Suzuki F; Brutkiewicz RR; Pollard RB
    Anticancer Res; 1986; 6(2):177-82. PubMed ID: 3085573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acceleration of age-associated immune decline and mortality by early repeated administration of bestatin to C57BL/6 mice.
    Bruley-Rosset M; Payelle B; Rappaport H
    J Biol Response Mod; 1986 Apr; 5(2):176-90. PubMed ID: 3488372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Restoration of impaired immune functions of aged animals by chronic bestatin treatment.
    Bruley-Rosset M; Florentin I; Kiger N; Schulz J; Mathé G
    Immunology; 1979 Sep; 38(1):75-83. PubMed ID: 159863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NK cells from mammary tumor bearing mice do not exert natural killer activity but function as antibody dependent cellular cytotoxicity effectors.
    Rivera LM; Lopez DM
    Anticancer Res; 1993; 13(1):177-84. PubMed ID: 8476211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ability of sera from mice treated with Ge-132, an organic germanium compound, to inhibit experimental murine ascites tumours.
    Suzuki F; Brutkiewicz RR; Pollard RB
    Br J Cancer; 1985 Nov; 52(5):757-63. PubMed ID: 3933536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.